| Name | 8-Bromo-2-chloro-6-fluoroquinazoline |
|---|---|
| Synonyms |
Quinazoline, 8-bromo-2-chloro-6-fluoro-
RB3131 8-Bromo-2-chloro-6-fluoroquinazoline QC-509 8-bromo-2-chloro-6-fluoro-quinazoline |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 217.7±33.0 °C at 760 mmHg |
| Molecular Formula | C8H3BrClFN2 |
| Molecular Weight | 261.478 |
| Flash Point | 85.5±25.4 °C |
| Exact Mass | 259.915222 |
| PSA | 25.78000 |
| LogP | 2.96 |
| Vapour Pressure | 0.2±0.4 mmHg at 25°C |
| Index of Refraction | 1.665 |
| HS Code | 2933990090 |
|---|
|
~91%
953039-63-9 |
| Literature: NOVARTIS VACCINES and DIAGNOSTICS, INC. Patent: WO2007/117607 A2, 2007 ; Location in patent: Page/Page column 332 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |